Related Experiment Video
Updated: Jun 29, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Sex differences in neonatal outcomes following prenatal opioid exposure
Nethra K Madurai1, Lauren L Jantzie1,2,3,4, Elizabeth Yen5,6,7
1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Insights
Prenatal opioid exposure impacts neonates, with biological sex influencing outcomes. Research is needed to understand sex-specific effects on infant brain development and health.
Area of Science:
- Neonatal outcomes
- Neuroscience
- Public Health
Background:
- The opioid epidemic poses a significant public health challenge, affecting pregnant individuals and infants.
- Understanding the impact of opioids on the developing brain during pregnancy and postnatally is crucial.
- Biological sex is a key factor in physiological processes and may influence neonatal outcomes in infants with opioid exposure.
Purpose of the Study:
- To review current literature on the effects of biological sex on neonatal outcomes following prenatal opioid exposure.
- To highlight the importance of considering sex as a biological variable in neonatal research.
- To inform strategies for improving the health of infants affected by prenatal opioid exposure.
Main Methods:
- Literature review of studies investigating sex differences in neonatal outcomes related to prenatal opioid exposure.
- Analysis of emerging clinical data on sex-specific effects in infants.
- Synthesis of findings on gene expression, feeding regulation, reward pathways, and white matter injury.
Main Results:
- Sex differences in opioid use disorder are established in adults but less understood in neonates.
- Emerging data suggest sex-specific effects in infants, including impacts on genes for feeding regulation and reward pathways.
- Female infants exposed to opioids prenatally may have increased susceptibility to white matter injury.
Conclusions:
- Biological sex significantly influences neonatal outcomes following prenatal opioid exposure.
- Further research into sex-specific effects is critical for targeted interventions and improved infant health.
- Understanding these sex differences is paramount for addressing the long-term health of individuals affected by the opioid epidemic.
Abstract:
The impact of the opioid epidemic on pregnant people and children is a growing public health crisis. Understanding how opioids affect the developing brain during pregnancy and postnatally remains a critical area of investigation. Biological sex plays a crucial role in all physiologic processes, with the potential for a significant impact on neonatal outcomes, including those infants with opioid exposure. Here, we aim to explore current literature on the effect of sex on neonatal outcomes following prenatal opioid exposure. Sex differences in adults with opioid use disorder have been well studied, including increased mortality among males and higher rates of psychiatric comorbidities and likelihood of relapse in females. However, such differences are not yet well understood in neonates. Emerging clinical data suggest sex-specific effects in infants with prenatal opioid exposure on the expression of genes related to feeding regulation and reward signaling pathways. Increased susceptibility to white matter injury has also been noted in female infants following prenatal opioid exposure. Understanding the impact of sex as a biological variable on neonatal outcomes following prenatal opioid exposure is paramount to improving the health and well-being of infants, children, and adults impacted by the opioid epidemic.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Factors Affecting Drug Response: Overview
Analgesia and Pain Management

